HORMONE-DEPENDENT PROSTATE CANCER

HORMONE-DEPENDENT PROSTATE CANCER was reported 70 times

HORMONE-DEPENDENT PROSTATE CANCER is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Radioactive Diagnostic Agent [EPC] 5 0.0016
1 Radioligand Therapeutic Agent [EPC] 10 0.0007
2 Androgen Receptor Inhibitor [EPC] 16 0.0002
3 alpha-Glucosidase Inhibitor [EPC] 1 0.0002
4 Microtubule Inhibitor [EPC] 20 0.0001
5 Chloride Channel Activator [EPC] 1 0.0001
6 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 5 0.0001
7 alpha-Adrenergic Blocker [EPC] 10 0.0001
8 Aldosterone Antagonist [EPC] 9 0.0001
9 Non-Standardized Plant Allergenic Extract [EPC] 1 0.0001
10 Xanthine Oxidase Inhibitor [EPC] 9 0.0001
11 Antimetabolite Immunosuppressant [EPC] 1 0.0000
12 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 5 0.0000
13 Gonadotropin Releasing Hormone Receptor Antagonist [EPC] 1 0.0000
14 Androgen [EPC] 1 0.0000
15 Provitamin D2 Compound [EPC] 1 0.0000
16 Phenothiazine [EPC] 1 0.0000
17 beta-Adrenergic Blocker [EPC] 10 0.0000
18 Angiotensin 2 Receptor Blocker [EPC] 10 0.0000
19 Dipeptidyl Peptidase 4 Inhibitor [EPC] 1 0.0000
20 Programmed Death Receptor-1 Blocking Antibody [EPC] 2 0.0000
21 Loop Diuretic [EPC] 9 0.0000
22 Leukocyte Growth Factor [EPC] 2 0.0000
23 Calcium [EPC] 2 0.0000
24 Non-Standardized Chemical Allergen [EPC] 1 0.0000
25 Arteriolar Vasodilator [EPC] 1 0.0000
26 Non-Standardized Food Allergenic Extract [EPC] 1 0.0000
27 Proton Pump Inhibitor [EPC] 7 0.0000
28 Fluoroquinolone Antibacterial [EPC] 1 0.0000
29 Nonsteroidal Anti-inflammatory Drug [EPC] 10 0.0000
30 Phosphodiesterase 5 Inhibitor [EPC] 1 0.0000
31 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
32 Dihydropyridine Calcium Channel Blocker [EPC] 2 0.0000
33 RANK Ligand Inhibitor [EPC] 1 0.0000
34 Corticosteroid [EPC] 6 0.0000
35 Factor Xa Inhibitor [EPC] 1 0.0000
36 Kinase Inhibitor [EPC] 1 0.0000
37 Platelet Aggregation Inhibitor [EPC] 1 0.0000